Discover 1,060 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,060
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Richmond VA, West Palm Beach FL, Miami FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Belimumab With Rituximab for Primary Membranous Nephropathy
for
Membranous Nephropathy, Nephrotic Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT03949855
Phase2, Recruiting
Active & Responsive
Responding With Evidence and Access for Childhood Headaches
Location: Philadelphia PA, Wilmington DE, Amherst NY,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 10 - 17
Code: NCT05889624
Recruiting
Active & Responsive
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
for
Coronary Artery Disease
Location: Albany NY, Flemington NJ, Bowie MD, Richmond VA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 18+
Code: NCT06713239
Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: The Bronx NY, Easton PA, Baltimore MD, Greenville NC,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06439082
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
for
Rett Syndrome
Location: Boston MA, New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Neurogene Inc.
Sex: Female
Age: 3+
Code: NCT05898620
Phase3, Recruiting
Active & Responsive
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation